Possible impact on milk supply rapid weight loss and low calorie intake may lower supply for some women, especially if your diet isnt being monitored carefully. When on GLP-1s, it is recommended to work with a nutritionist to ensure you are getting an increased amount of protein and other nutrients.
The introduction of GLP-1 agonists to augment weight loss has become a topic of interest for many postpartum mothers. Our study aims to investigate the transmission of semaglutide into human milk in the first steps to ensure the safety and health of both lactating mothers and their breastfed infants.
This concern applies to any rapid weight loss method during breastfeeding, not just GLP-1 medications. But because GLP-1 agonists can produce substantial weight loss (sometimes 1 to 2 pounds per week or more), the rate of fat mobilization could be significant enough to affect milk quality.
Can you take GLP-1 medications like Ozempic or Mounjaro while breastfeeding? Learn what research says about breast milk transfer, milk supply, nutrition, and postpartum weight loss.
Jacqueline Cooper, IBCLC Are GLP-1 Weight Loss Drugs Safe for Breastfeeding? The emergence of weight loss medications like semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) has caught the attention of many new mums looking for support in managing their weight.
Such details provide a deeper understanding and appreciation for Glp-1 And Weight Loss In Lactation.
GLP-1 receptor agonists (like semaglutide, liraglutide, or tirzepatide) were originally developed to help manage type 2 diabetes by improving blood sugar control. They also slow stomach emptying and reduce appetite which is why theyve become widely used for weight loss. They can be effective, but theyre also powerful medications and their safety depends on timing, body needs, and ...
GLP-1 weight-loss medications are designed to resist this breakdown, allowing them to stay active in the body for much longer - from several days to even weeks, depending on the medication and dose.
